0001415889-24-024183.txt : 20241001 0001415889-24-024183.hdr.sgml : 20241001 20241001161507 ACCESSION NUMBER: 0001415889-24-024183 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241001 FILED AS OF DATE: 20241001 DATE AS OF CHANGE: 20241001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jin David CENTRAL INDEX KEY: 0001930732 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35366 FILM NUMBER: 241343441 MAIL ADDRESS: STREET 1: C/O AVENUE THERAPEUTICS, INC. STREET 2: 1140 AVENUE OF THE AMERICAS, FLOOR 9 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 1111 KANE CONCOURSE STREET 2: SUITE 301 CITY: BAY HARBOR ISLANDS STATE: FL ZIP: 33154 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 4 1 form4-10012024_041004.xml X0508 4 2024-10-01 0001429260 Fortress Biotech, Inc. FBIO 0001930732 Jin David C/O FORTRESS BIOTECH, INC. 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 false true false false Chief Financial Officer 0 Common Stock, par value $0.001 2024-10-01 5 A 0 2625 1.2283 A 240893 D The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Total holdings include 230,000 shares underlying deferred restricted stock units. /s/ David Jin 2024-10-01